# 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Canonical URL: https://biopharmsignal.com/news/ETNB/89bio-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4
Ticker: ETNB
Company: 89bio, Inc.
Source: 89bio, Inc.
Published: 2025-09-05 20:05 EST
Original Source URL: https://ir.89bio.com
## Summary

SAN FRANCISCO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that

## Article Body
SAN FRANCISCO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that
## Recent Company News
- 2025-09-18 05:02 EST — [89bio, Inc. Announces Agreement to be Acquired by Roche](https://biopharmsignal.com/news/ETNB/89bio-inc-announces-agreement-to-be-acquired-by-roche) — Source: 89bio, Inc.
- 2025-09-05 20:05 EST — [89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/ETNB/89bio-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4) — Source: 89bio, Inc.
- 2025-08-28 20:05 EST — [89bio to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/ETNB/89bio-to-participate-in-upcoming-investor-conferences) — Source: 89bio, Inc.
- 2025-08-07 20:06 EST — [89bio Reports Second Quarter 2025 Financial Results and Corporate Updates](https://biopharmsignal.com/news/ETNB/89bio-reports-second-quarter-2025-financial-results-and-corporate-updates) — Source: 89bio, Inc.
- 2025-08-04 20:05 EST — [89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/ETNB/89bio-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4-e3e28fab) — Source: 89bio, Inc.
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)